2-(4-fluorophenyl)-3-(4-methanesulfonyl-phenyl)-1-methyl-6,7-dihydro-5H-pyrrolizine | 350016-25-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 2-(4-fluorophenyl)-3-(4-methanesulfonyl-phenyl)-1-methyl-6,7-dihydro-5H-pyrrolizine
• 英文别名: 6-(4-fluorophenyl)-7-methyl-5-(4-methylsulfonylphenyl)-2,3-dihydro-1H-pyrrolizine
• CAS: 350016-25-0
• 化学式: C₂₁H₂₀FNO₂S
• 分子量: 369.46
• InChiKey: PBQUFSVICNEOTA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  47.4
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Benzamide derivatives for the treatment of diseases mediated by cytokines
  申请人：ASTRAZENECA AB

  公开号：US20030212068A1

  公开（公告）日：2003-11-13

  1 The invention concerns amide derivatives of Formula (I), wherein R 3 is (1-6C)alkyl or halogeno; m is 1-3 and R 1 is selected from substituents such as: (A) hydroxy, halogeno, (1-6C)alkyl, (1-6C)alkoxy, aryl, heteroaryl and heterocyclyl; and (B) di-[(1-6C)alkyl]amino-(1-6C)alkyl, (1-6C)alkoxy-(2-6C)alkoxy, di-[(1-6C)alkyl]amino-(2-6C)alkoxy, aryloxy, heteroaryloxy, heteroaryl-(1-6C)alkoxy, heterocyclyloxy and heterocyclyl-(1-6C)alkoxy; p is 0-2 and R 2 is a substituent such as hydroxy and halogeno; q is 0-4; and R 4 is aryl or cycloalkyl which bears 1-3 substituents such as: (C) hydrogen, hydroxy, halogeno and heterocyclyl; and (D) heteroaryl-(1-6C)alkoxy and heterocyclyl-(1-6C)alkoxy, provided that a substituent on R 4 is selected from paragraph (C) only if at least one R 1 group is selected from paragraph (B); processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.

  该发明涉及式(I)的酰胺衍生物，其中R3是(1-6C)烷基或卤素；m为1-3，R1被选择为以下取代基之一：(A)羟基、卤素、(1-6C)烷基、(1-6C)烷氧基、芳基、杂芳基和杂环基；和(B)二-[(1-6C)烷基]氨基-(1-6C)烷基、(1-6C)烷氧基-(2-6C)烷氧基、二-[(1-6C)烷基]氨基-(2-6C)烷氧基、芳氧基、杂芳氧基、杂芳基-(1-6C)烷氧基、杂环氧基和杂环基-(1-6C)烷氧基；p为0-2，R2是羟基和卤素等取代基；q为0-4；R4是芳基或环烷基，其带有1-3个取代基，例如：(C)氢、羟基、卤素和杂环基；和(D)杂芳基-(1-6C)烷氧基和杂环基-(1-6C)烷氧基，但仅当至少一个R1基团选择自段(B)时，才从段(C)中选择R4上的取代基；制备它们的方法，含有它们的制药组合物，以及它们在治疗由细胞因子介导的疾病或医疗状况中的应用。
• Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
  申请人：——

  公开号：US20040122002A1

  公开（公告）日：2004-06-24

  The present invention relates to fused pyrrole compounds of the formula 1. 1 in which at least one of the radicals R1, R2, R3 is 4-sulphur-substituted phenyl. These compounds are in particular pyrrolizines, indolizines and heteroanalogues having selective inhibitory action on isoenzyme-2 of prostaglandin H synthase (COX-2). The invention also relates to pharmaceutical compositions which contain these compounds; and the use of these compounds for the treatment of disorders of the rheumatic type.

  本发明涉及式1.1的融合吡咯化合物，其中至少一个基团R1、R2、R3是4-硫代取代苯基。这些化合物特别是吡咯啉、吲哚啉和杂环类似物，具有对前列腺素H合成酶同工酶2的选择性抑制作用。本发明还涉及含有这些化合物的药物组合物；以及使用这些化合物治疗风湿性疾病的方法。
• ANELLIERTE PYRROLVERBINDUNGEN, DIESE ENTHALTENDE PHARMAZEUTISCHE MITTEL UND DEREN VERWENDUNG
  申请人：MERCKLE GMBH

  公开号：EP1246825B1

  公开（公告）日：2003-12-17
• BENZAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY CYTOKINES
  申请人：AstraZeneca AB

  公开号：EP1077931B1

  公开（公告）日：2004-11-17
• US6579872B1
  申请人：——

  公开号：US6579872B1

  公开（公告）日：2003-06-17